No TP53 mutation have been detected so far in our analyses, and there was only localized immunohistochemical staining in a few cells, suggesting that GA-FGM is a lower-grade malignancy than common-type gastric adenocarcinoma. Here, TP53 is linked to gastric adenocarcinoma.